Page 673 - Small Animal Internal Medicine, 6th Edition
P. 673

CHAPTER 37   The Exocrine Pancreas   645




  VetBooks.ir  Drugs Used for Hepatobiliary and Pancreatic Disorders—cont’d  INDICATIONS AND COMMENTS

                                         DOSAGE
             DRUG NAME (TRADE NAME)
             Maropitant (Cerenia)        Dogs > 8 wk—1 mg/kg SC     Centrally acting antiemetic (NK1 receptor antagonist)
                                           q24h for up to 5 days, or   Antiemetic of choice in canine pancreatitis, no obvious
                                           2 mg/kg orally q24h for up   prokinetic effect
                                           to 5 days                Use with care in liver disease because metabolized in
                                         Cats > 16 wk—1 mg/kg SC     the liver, so do not use if significant liver dysfunction
                                           q24h for up to 5 days; not   Not licensed for oral use cats
                                           currently licensed for oral
                                           use in cats
             Ondansetron (Zofran)        Cats and dogs—0.5 mg/kg IV   Refractory vomiting; may be contraindicated in
                                           loading dose followed by   pancreatitis because it has been reported to trigger
                                           0.5 mg/kg/h infusion q6h   vomiting in humans
                                           or 0.5-1 mg/kg PO q12-24h

             Antiencephalopathic
             Lactulose                   5-15 mL PO q8h (dogs)      Hepatic encephalopathy with acquired or congenital
                                         0.25-1 mL PO q8h (cats)     portosystemic shunts
                                         Can also be given as retention   Overdose produces diarrhea
                                           enema in acute           Titrate to effect (two or three soft bowel movements/
                                           encephalopathy            day)
             Antibiotics (e.g., ampicillin,   See antibacterial section
               metronidazole, neomycin)
             Propofol                    Constant rate infusion; rate   Drug of choice for seizures because of liver disease,
                                           calculated by giving initial   hepatic encephalopathy
                                           bolus to effect (usually   Should not be used in pancreatitis because it is a lipid
                                           ≈1 mg/kg) and timing      vehicle
                                           duration of action; usually
                                           ≈0.1-0.2 mg/kg/min
             Phenobarbital               5-10 mg/kg PO q24h         Can be used prophylactically before and immediately
                                           preoperatively followed by   after surgery to reduce risk of postoperative seizures
                                           3-5 mg/kg q12h            after ligation of PSS, but anecdotal evidence of
                                           postoperatively for 3 wk  effectiveness
             Levetiracetam (Keppra)      Dogs—20 mg/kg PO q8 for    Efficacy for preventing hepatic encephalopathy only
                                           minimum of 24 hours before   reported with pretreatment before surgery for
                                           surgery for portosystemic   portosystemic shunts
                                           shunt. Doses of 30 or    Drug appears most effective short term
                                           60 mg/kg IV have been    Efficacy of longer term oral treatment not demonstrated
                                           reported in status epilepticus
                                           in dogs

             Antiinflammatory-Antifibrotic
             (Note spironolactone also has putative antifibrotic effect—see diuretic section)
             Prednisolone (prednisone)   Antiinflammatory           Antiinflammatory or immunosuppressive doses in
                                           dose—0.5 mg/kg PO q24h    lymphocytic cholangitis in cats; immunosuppressive
                                         Immunosuppressive           doses in suspected autoimmune chronic hepatitis in
                                           dose—1-2 mg/kg PO q24h    dogs (see text), and in suspected immune-mediated
                                         Taper at 0.5 mg/kg PO q24h   pancreatitis in English Cocker Spaniels (see text)
                                           or q48h
                                                                    Avoid in suppurative cholangitis
                                                                    Avoid in portal hypertension or animals with ascites
                                                                     (potential GI ulceration)
                                                                    Avoid use of dexamethasone—very ulcerogenic
                                                                                                          Continued
   668   669   670   671   672   673   674   675   676   677   678